Markets:

Overview

News

Currencies

International

Treasuries

IQVIA Holdings, Inc. Common Stock (NY:IQV)

186.91 +15.63 (+9.13%)

Streaming Delayed Price Updated: 3:36 PM EDT, Jun 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Lockheed, General Motors Tumble, Gold Hits 1-Month Highs: What's Moving Markets Tuesday? ↗

July 22, 2025

It was a quiet Tuesday on Wall Street, as major indexes edged lower with investors pausing ahead of a critical wave of tech earnings.

Via Benzinga

Discover which S&P500 stocks are making waves on Tuesday. ↗

July 22, 2025

Let's delve into the developments on the US markets in the middle of the day on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

Preview: IQVIA Hldgs's Earnings ↗

July 21, 2025

Via Benzinga

Is IQVIA Hldgs Gaining or Losing Market Support? ↗

July 01, 2025

Via Benzinga

Why IQVIA (IQV) Stock Is Trading Up Today

July 22, 2025

Shares of clinical research company IQVIA (NYSE: IQV) jumped 15.9% in the morning session after the company reported second-quarter financial results that beat Wall Street expectations and raised its...

Via StockStory

Topics Artificial Intelligence

Tuesday's session: gap up and gap down stock in the S&P500 index ↗

July 22, 2025

Let's have a look at the S&P500 gap up and gap down stocks in today's session.

Via Chartmill

D.R. Horton, IQVIA Holdings, Northrop Grumman And Other Big Stocks Moving Higher On Tuesday ↗

July 22, 2025

Via Benzinga

Iqvia Surges As 'Pluses' Outweigh 'Minuses' In Its Second-Quarter Report ↗

July 22, 2025

Iqvia stock surged Tuesday after the clinical resource organization widely beat most second-quarter metrics.

Via Investor's Business Daily

Topics Government

Tuesday's pre-market session: top gainers and losers in the S&P500 index ↗

July 22, 2025

Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 22, 2025

Via Benzinga

IQVIA (NYSE:IQV) Beats Q2 Sales Targets, Stock Soars

July 22, 2025

Clinical research company IQVIA (NYSE: IQV) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 5.3% year on year to $4.02 billion. The company’s full-year revenue...

Via StockStory

IQVIA Reports Second-Quarter 2025 Results

July 22, 2025

From IQVIA Holdings Inc.

Via Business Wire

Earnings Scheduled For July 22, 2025 ↗

July 22, 2025

Via Benzinga

IQVIA Earnings: What To Look For From IQV

July 20, 2025

Clinical research company IQVIA (NYSE: IQV) will be reporting earnings this Tuesday before the bell. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

3 Low-Volatility Stocks We Approach with Caution

July 18, 2025

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Via StockStory

Healthcare’s $110B AI Surge Is Picking Up Speed—and It’s Just the Beginning

July 08, 2025

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:GEHC),(NASDAQ:WAY),(NYSE:CI),(NYSE:IQV) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025

July 01, 2025

From IQVIA

Via Business Wire

3 Healthcare Stocks Skating on Thin Ice

June 30, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Via StockStory

Topics Stocks

Trump Vows To Cut 'The Best Deal' On Drug Prices. What To Expect. ↗

June 26, 2025

President Donald Trump, ever the negotiator, is angling to lower drug prices through his Most Favored Nation policy.

Via Investor's Business Daily

Topics Government

Drug Development Inputs & Services Stocks Q1 Highlights: IQVIA (NYSE:IQV)

June 16, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how IQVIA (NYSE:IQV) and the rest...

Via StockStory

IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement’

June 16, 2025

From IQVIA

Via Business Wire

Nvidia Just Partnered With A Weight-Loss Giant, But It's Not About Pills ↗

June 12, 2025

Nvidia teams up with Novo Nordisk and IQVIA to boost AI-powered drug development and streamline complex pharmaceutical workflows.

Via Benzinga

IQVIA Launches New AI Agents for Life Sciences and Healthcare

June 11, 2025

From IQVIA

Via Business Wire

IQVIA Stock: Stuck In A Time Spiral - Value Play Or Bull Trap? ↗

June 10, 2025

IQVIA stock may look ready for a breakout, but Adhishthana analysis reveals a complex time spiral that could last until 2030.

Via Benzinga

Wednesday's session: top gainers and losers in the S&P500 index ↗

June 04, 2025

Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.

Via Chartmill

Which S&P500 stocks are moving on Wednesday? ↗

June 04, 2025

Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

IQVIA Announces Pricing of Senior Notes

June 02, 2025

From IQVIA Holdings Inc.

Via Business Wire

IQVIA Announces Offering of Senior Notes

June 02, 2025

From IQVIA Holdings Inc.

Via Business Wire

3 Value Stocks with Mounting Challenges

June 02, 2025

Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few...

Via StockStory

Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly ↗

May 29, 2025

Eli Lilly is rapidly encroaching on Novo Nordisk's yearslong lead in GLP-1 drugs. Can Novo hold its tentpole position?

Via Investor's Business Daily

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.